What Happened in October 2026?

In almost every Pakistani neighbourhood, the same scene plays out every day: you visit your doctor's clinic, and before you leave, the clinic's own counter hands you the medicines — sometimes in a paper bag, sometimes with the clinic's name printed on it. For years, many doctors have run full dispensaries and even medical stores inside their clinics. Patients rarely asked whether the clinic was legally allowed to sell them those medicines. On 2 October 2026, Pakistan's Federal Constitutional Court (FCC) gave a clear answer.

A two-judge bench headed by Chief Justice Aminuddin Khan, with Justice Ali Baqar Najafi, ruled that a registered medical practitioner may dispense medicines to his own patients under Section 31(4)(a) of the Pharmacy Act, 1967 — but that this protection does not allow a doctor to run a retail medical store without a drug-sale licence under the Drugs Act, 1976. The detailed nine-page judgment was reported on 5 October 2026.

In plain words: giving your own patient the medicine they need is one thing; running a shop that sells medicines like a business is another. The court drew a firm legal line between the two — and that line has big consequences for clinic owners across Pakistan.

The Case: How It All Started

The dispute did not begin in 2026. It began on 21 January 2020, when drug inspectors inspected the premises of several doctors in Khyber Pakhtunkhwa. The inspectors found dispensaries and medical stores operating inside the doctors' clinics. They seized the medicines found there under Form-6 (the official seizure receipt under the drug laws) and issued show-cause notices to the doctors, who were accused of selling medicines without the required drug-sale licences.

Instead of replying to the show-cause notices, the doctors went to the Peshawar High Court. On 5 June 2023, the High Court's D.I. Khan bench, in Writ Petition No. 144-D/2020, restrained the regulatory authorities from proceeding against the doctors. That order effectively shielded the doctors' dispensaries from regulatory action for three years.

The Khyber Pakhtunkhwa government, through its Secretary of the Health Department, challenged that order. The case was originally filed before the Supreme Court of Pakistan under Article 185(3) of the Constitution — but after the Constitution (Twenty-seventh Amendment) Act, 2025 created the Federal Constitutional Court, the matter was transferred to the new court. The FCC heard the case as C.P.L.A. No. 538-P/2023 — Government of Khyber Pakhtunkhwa v. Dr. Muhammad Rizwan Rajpoot and others — on 23 September 2026, and delivered its judgment on 2 October 2026.

The Exact Holding: Two Rules, One Verdict

The FCC's ruling is best understood as two rules working together:

Rule 1: Doctors may dispense to their own patients. Section 31(4)(a) of the Pharmacy Act, 1967 protects a registered medical practitioner who prescribes and dispenses medicine to his own patients. This is the everyday, legitimate practice of a doctor handing medicine to the patient sitting in front of him. The court kept this protection intact.

Rule 2: Doctors may NOT run a retail drug business without a licence. Under Section 23(1)(c) of the Drugs Act, 1976, no person may sell drugs without a licence. The court held that a doctor's professional registration as a medical practitioner does not exempt him from this requirement. Being a registered doctor does not give you a free pass to operate a medical store.

The judgment makes the distinction turn on what the clinic is actually doing: is it incidentally dispensing medicines to its own patients as part of treatment, or is it operating as a retail sales outlet? The court said this question must be answered on evidence — things like the quantities of stock kept, sales records, purchase invoices, and prescriptions — and it is the statutory drug authorities, not the High Court in a writ petition, who must examine that evidence first.

Crucially, the FCC set aside the Peshawar High Court's 5 June 2023 judgment and restored the regulatory proceedings. The doctors can now reply to the show-cause notices and present their records, and the authorities must decide the allegations independently. The court was careful to say it was not prejudging anyone's guilt — the doctors get their chance to defend themselves before the proper forum.

Why the Peshawar High Court's Order Was Set Aside

There is an important procedural lesson in this verdict. The doctors had gone to the High Court at the show-cause notice stage — before the drug authorities had even decided the case against them. The FCC held that courts should generally not interfere at the show-cause stage unless there are truly exceptional circumstances, and those circumstances were absent here.

This is a well-known legal principle: a show-cause notice is an invitation to explain yourself, not a final order. Running to court before answering it short-circuits the entire regulatory process. The FCC's message was blunt — the doctors should have replied to the notices first and let the drug authorities do their job. If the authorities had then acted unlawfully, the courts would have been open to them.

The judgment also upheld the drug inspectors' actions. The doctors had questioned whether the inspectors had the authority to inspect and seize. The court found no evidence that the inspector lacked authority — the inspections and Form-6 seizures were lawful.

Dispensing vs Selling: Where Is the Legal Line?

This is the part of the verdict that matters most in real life, so let us be precise about it.

Dispensing to your own patients (allowed): A doctor examines a patient, prescribes treatment, and hands over the medicine needed for that treatment from a modest stock kept in the clinic. This is an extension of the doctor's treatment of his own patient. Section 31(4)(a) of the Pharmacy Act, 1967 protects exactly this.

Running a retail medical store (needs a licence): A clinic maintains a full drug inventory, sells medicines to walk-in customers who may not be the doctor's patients, keeps sales records and cash registers like a shop, issues bills, and runs the counter as a commercial business. This is a drug business, and under Section 23(1)(c) of the Drugs Act, 1976, it requires a drug-sale licence — whether the owner is a doctor or not.

How will the authorities tell the difference? The FCC pointed to the evidence they will look at:

  • Stock quantities — a small stock for patient needs looks like dispensing; a warehouse of inventory looks like a shop.

  • Sales records and invoices — are medicines being sold and recorded like retail transactions?

  • Prescriptions — are the medicines going to the doctor's own patients, or to the general public?

  • Purchase bills — where is the stock coming from, and in what volumes?

No single factor decides the matter. The authorities must look at the whole picture. But the direction of the verdict is unmistakable: a clinic counter that functions as a retail pharmacy is a retail pharmacy in the eyes of the law, and it needs the same licence as any other.

Licence Requirements Under the Drugs Act, 1976

The Drugs Act, 1976 is the main federal law controlling the manufacture, import, storage, and sale of drugs in Pakistan. Its scheme is straightforward:

  • Section 23 prohibits the sale of drugs except in accordance with the conditions of a licence. Section 23(1)(c) is the specific provision the FCC relied on: no one may sell drugs without a licence.

  • Licences for the sale of drugs are granted under rules framed by the provincial governments (such as the Punjab, Sindh, Khyber Pakhtunkhwa, and Balochistan Drugs Rules). The application goes to the provincial drug authority, and the premises must meet the prescribed requirements.

  • A full pharmacy must operate under the supervision of a registered pharmacist. A medical store operates under a qualified person meeting the prescribed qualifications. These are different categories of retail drug outlets, and the licence conditions differ accordingly.

  • The licence must be displayed at the premises, and the outlet must keep proper records of purchases and sales.

The practical point for doctors is simple: if your clinic counter sells medicines like a shop, you must apply for and hold a drug-sale licence from the provincial drug authority, just like any other medical store owner. Your PMDC registration as a doctor is a licence to practise medicine — it is not a licence to sell drugs.

Who Are Drug Inspectors and What Powers Do They Have?

The 2020 inspection that started this whole case was carried out by drug inspectors — and the FCC's verdict has effectively told them their enforcement powers stand. So who are they, and what can they do?

Drug inspectors are appointed by the federal and provincial governments under Section 17 of the Drugs Act, 1976. They are the field officers of the drug regulatory system. Their powers, mainly under Sections 18 and 19 of the Act, include:

  • Inspecting any premises where drugs are manufactured, stored, stocked, exhibited for sale, or sold — including clinics, dispensaries, medical stores, and pharmacies.

  • Taking samples of drugs for test or analysis by the official drug testing laboratories.

  • Seizing drugs, stock registers, and records where they suspect a violation of the Act — this seizure is recorded on Form-6, the official seizure memo, which is exactly what happened in the January 2020 inspection at the heart of this case.

  • Issuing show-cause notices and initiating the process that can lead to prosecution.

  • Sealing premises operating in violation of the law, as the ICT drug control authorities did in Islamabad after the FCC verdict (more on that below).

Obstructing a drug inspector or disobeying his lawful authority is itself an offence under the Drugs Act. If an inspector visits your clinic, the lawful response is to cooperate, show your records, and answer the show-cause notice — the FCC verdict is a warning that running to court instead will not help.

Penalties for Selling Drugs Without a Licence

The Drugs Act, 1976 does not treat unlicensed drug sale as a minor paperwork lapse. The offences, penalties, and procedure are set out in Chapter IV of the Act, and cases are tried by special Drug Courts:

  • Selling drugs without a licence (contravention of Section 23) falls under the general penalty clause in Section 27(4): imprisonment for up to one year, or a fine of up to Rs 5,000, or both.

  • Obstructing a drug inspector in the exercise of his powers, or disobeying his lawful authority, is punishable under Section 27(3) with imprisonment of up to one year, or a fine of up to Rs 10,000, or both.

  • Far heavier punishments apply to more serious drug offences: selling spurious or unregistered drugs carries three to ten years' imprisonment and a fine of up to Rs 100,000 under Section 27(1), and selling counterfeit drugs can bring up to seven years under Section 27(2).

A doctor running an unlicensed medical store therefore faces not only the closure or sealing of the outlet but also criminal prosecution before a Drug Court. And because the FCC has restored the regulatory proceedings in the KP case, the doctors in that case will now have to face precisely this process.

The Verdict Is Already Being Enforced

This was not a judgment that sat on paper. Within days of the FCC ruling, enforcement began. In Islamabad, the Pharmacy Services & Drug Control (PS&DC), Health Department, ICT, intensified its enforcement drive, citing the FCC judgment directly. A PS&DC-ICT team — Drug Inspectors Ms. Amber Basharat, Mr. Gulzaib Khan, and Ms. Tahreem Sara, under the supervision of the Secretary of the Quality Control Board, Sardar Shabbir Ahmed — found a pharmacy operating inside a medical centre that was selling therapeutic goods without a drug-sale licence, besides overpricing. The premises were sealed in accordance with the law.

PS&DC-ICT also directed all registered medical practitioners to comply strictly with the drug laws, and directed all licensed distributors to immediately stop supplying medicines to unlicensed pharmacies, medical stores, medical centres, or other outlets. It warned that violations would invite strict regulatory and legal action, and that inspections would continue.

The message to clinic owners is clear: the authorities are now acting on this verdict, and "everyone does it" is no longer a defence.

What This Means for Patients

The verdict is mainly about doctors and drug regulation, but it affects patients too. Here is what you should know:

Your right to a prescription. A doctor must give you a proper prescription. You are entitled to take that prescription to any licensed pharmacy or medical store of your choice — you are not obliged to buy medicines from your doctor's own counter. If a clinic pressures you to buy only from its in-house store, that is a red flag.

Prices and overpricing. One of the Islamabad enforcement cases involved overpricing at an unlicensed outlet. Licensed pharmacies operate under price controls for scheduled drugs. If you suspect you are being overcharged at a clinic counter, you can compare prices at licensed pharmacies and complain to the provincial drug authorities or DRAP.

Generic substitution. In Pakistan, doctors usually prescribe medicines by brand name, and pharmacists do not have a general legal right to substitute a different brand or a generic equivalent without the prescriber's agreement. This verdict does not change that position — but it does mean that where you buy your medicine, you should be buying from a licensed outlet with a qualified person who can at least counsel you on the prescription.

Safety of medicines. The licensing system exists to protect you. A licensed pharmacy or medical store is subject to inspection, must buy from licensed distributors, and must keep records. An unlicensed clinic counter operates outside this chain of accountability — which is exactly why the court insisted that drug businesses need licences regardless of who owns them.

What Clinic Owners Should Do Now: Practical Steps

If you are a doctor running a clinic with a dispensary or medicine counter, here is a sensible, step-by-step response to the October 2026 verdict:

  1. Audit what you actually do. Be honest with yourself: do you only hand medicines to your own examined patients as part of their treatment, or does your counter sell to walk-in customers, keep retail-style stock, and function as a shop? If it is the latter, you are running a drug business.

  1. Decide: licence or stop selling. If your counter is a retail outlet, you have two lawful options — obtain a drug-sale licence from the provincial drug authority (meeting the premises and qualified-person requirements), or stop retail sales and limit yourself to dispensing to your own patients under Section 31(4)(a) of the Pharmacy Act, 1967.

  1. Apply for the licence properly. The licence application goes to the provincial drug authority under the provincial Drugs Rules. You will need compliant premises, the prescribed qualified person (a registered pharmacist for a pharmacy), proper storage conditions, and record-keeping systems. Start the process now, before an inspector visits.

  1. Buy only from licensed distributors. After the ICT directive, licensed distributors have been told to stop supplying unlicensed outlets. If your supplier cuts you off, that is the law working as intended — do not turn to grey-market sources, which can expose you to spurious-drug offences carrying three to ten years' imprisonment.

  1. Keep proper records. Purchase invoices, stock registers, sales records, and prescriptions are exactly the evidence the FCC said the authorities will examine. Maintain them whether you are dispensing or selling — they are your best defence if you are ever inspected.

  1. Never ignore a show-cause notice. The single clearest procedural lesson of this verdict: reply to the show-cause notice, with records and legal assistance, before the proper authority. Going to the High Court first did not save the KP doctors — it only delayed the proceedings by three years, and the FCC has now sent the case back to the regulators.

  1. Cooperate with drug inspectors. Obstruction is a separate offence punishable with up to one year's imprisonment. Show the inspector your licence, your records, and your stock. If you believe the inspector is acting beyond his authority, note your objection and challenge it through proper legal channels — do not physically resist.

Common Myths — Busted

Myth 1: "I am a registered doctor, so I don't need a drug-sale licence." Reality: The FCC expressly rejected this. Your medical registration lets you practise medicine; it does not exempt you from Section 23(1)(c) of the Drugs Act, 1976. Selling drugs without a licence is unlawful whether you are a doctor or not.

Myth 2: "Section 31(4)(a) of the Pharmacy Act lets doctors sell any medicines." Reality: No. That provision protects dispensing to a doctor's own patients — it is not a blanket permission to run a retail drug business. The FCC drew this line in unmistakable terms.

Myth 3: "If I get a show-cause notice, I should rush to the High Court for a stay." Reality: That is exactly what the KP doctors did, and the FCC set the resulting 2023 order aside. Courts do not normally interfere at the show-cause stage without exceptional circumstances. Reply to the notice first.

Myth 4: "Drug inspectors have no power over a doctor's clinic." Reality: The FCC found no evidence that the inspectors lacked authority and upheld the inspections and Form-6 seizures. Drug inspectors can inspect clinics, take samples, and seize stock where they suspect violations.

Myth 5: "This only affects Khyber Pakhtunkhwa." Reality: The case came from KP, but the FCC's interpretation of the Drugs Act, 1976 and the Pharmacy Act, 1967 applies across Pakistan. The ICT authorities in Islamabad were already enforcing it within days of the judgment.

Myth 6: "Small clinic dispensaries are too minor for the authorities to bother with." Reality: The 2020 inspection that started this case targeted ordinary clinic dispensaries, and the post-verdict sealing in Islamabad hit a pharmacy inside a medical centre. Size is no shield — the legal test is whether you are selling without a licence.

Frequently Asked Questions

Q: Can my doctor give me medicines at his clinic after this verdict? A: Yes. The FCC expressly protected a registered medical practitioner's right to dispense medicines to his own patients under Section 31(4)(a) of the Pharmacy Act, 1967. What the verdict prohibits is the doctor running a retail medical store — selling drugs like a shop — without a drug-sale licence.

Q: How do I know whether my clinic's medicine counter is legal? A: Ask whether it holds a drug-sale licence issued by the provincial drug authority — a licensed outlet must display its licence. If the counter sells to walk-in customers, keeps large retail stock, and issues sale bills like a shop but has no licence, it is operating unlawfully under this verdict.

Q: Am I forced to buy medicines from my doctor's clinic? A: No. You are entitled to a prescription and to buy your medicines from any licensed pharmacy or medical store you choose. No clinic can lawfully compel you to purchase from its own counter.

Q: What is a Form-6 seizure? A: Form-6 is the official seizure memo used under the drug laws. When a drug inspector seizes medicines or records during an inspection, the seizure is documented on Form-6, which serves as the formal record. The January 2020 seizures that led to this case were made under Form-6.

Q: What should a doctor do if a drug inspector visits the clinic? A: Cooperate: show your licence (if any), purchase invoices, stock records, and prescriptions. Obstructing an inspector is a separate offence punishable with up to one year's imprisonment or a fine up to Rs 10,000. If you receive a show-cause notice, reply to it with your records and legal counsel before the proper authority — do not rush to court first.

Q: Does the verdict cancel the doctors' right to defend themselves? A: No. The FCC restored the regulatory proceedings but did not decide the doctors' guilt. They may now submit replies and records to the show-cause notices, and the drug authorities must decide the allegations independently and on the evidence.

The Bigger Picture: Why This Ruling Matters

Step back from the legal technicalities, and the October 2026 verdict tells a larger story about how Pakistan regulates the medicine supply chain. Every pill sold outside the licensed system is a pill whose quality, storage, and price nobody can verify. Unlicensed clinic counters buy and sell outside the documented chain — and when something goes wrong, whether it is a spurious drug or gross overpricing, the patient has no regulator to turn to. The FCC's insistence that every retail drug outlet needs a licence, regardless of who owns it, is fundamentally about closing that gap.

There is also a conflict-of-interest dimension the court did not need to spell out: a doctor who profits from every tablet he sells has a financial incentive to prescribe more. Separating prescribing from retail selling — the model the verdict pushes toward — removes that incentive and protects patients from over-prescription.

For the legal system, the verdict reinforces an important discipline: regulatory forums first, courts later. The three-year detour through the Peshawar High Court delayed justice for everyone — the doctors lived under a cloud of unresolved allegations, and the regulators were frozen. By restoring the proceedings and insisting that show-cause notices be answered rather than evaded, the FCC has strengthened the drug regulatory machinery itself.

Finally, the verdict is a reminder that the Federal Constitutional Court, created under the 27th Amendment, is now actively shaping Pakistan's regulatory law. Cases that once lingered in the Supreme Court's backlog are being decided — and, as the Islamabad sealing drive shows, the executive is listening.

The Bottom Line

The Federal Constitutional Court's October 2026 verdict draws one clear line: a doctor may dispense medicines to his own patients, but he may not run a retail medical store without a drug-sale licence under the Drugs Act, 1976. The Peshawar High Court's 2023 order shielding the KP doctors' dispensaries has been set aside, the regulatory proceedings have been restored, and enforcement — including premises being sealed in Islamabad — has already begun. For clinic owners, the choice is now simple and unavoidable: get the licence, or stop selling. For patients, the verdict protects your right to a prescription you can take to any licensed pharmacy, and to medicines bought through a regulated, accountable chain.

This article provides general legal information for readers in Pakistan and is not legal advice. Drug regulation involves federal and provincial laws and rules that can be technical, and every clinic's situation is different. For your specific case, please consult a qualified advocate.